Skip to content

ASPRAEIPYBEUEV-UHFFFAOYSA-N

C45H48F10N4O6 — CID 157217755

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC1-[4-[2-(2,4-difluorophenoxy)ethyl]piperazin-1-yl]-4-[4-(trifluoromethoxy)phenyl]butan-1-one;1-[4-[2-(2,4-difluorophenoxy)ethyl]piperazin-1-yl]-3-[4-(trifluoromethoxy)phenyl]propan-1-one
SMILESO=C(CCCc1ccc(OC(F)(F)F)cc1)N1CCN(CCOc2ccc(F)cc2F)CC1.O=C(CCc1ccc(OC(F)(F)F)cc1)N1CCN(CCOc2ccc(F)cc2F)CC1
InChIInChI=1S/C23H25F5N2O3.C22H23F5N2O3/c24-18-6-9-21(20(25)16-18)32-15-14-29-10-12-30(13-11-29)22(31)3-1-2-17-4-7-19(8-5-17)33-23(26,27)28;23-17-4-7-20(19(24)15-17)31-14-13-28-9-11-29(12-10-28)21(30)8-3-16-1-5-18(6-2-16)32-22(25,26)27/h4-9,16H,1-3,10-15H2;1-2,4-7,15H,3,8-14H2
InChIKeyASPRAEIPYBEUEV-UHFFFAOYSA-N
MW930.88 g/mol
LogP8.43
Rot. Bonds17

About ASPRAEIPYBEUEV-UHFFFAOYSA-N

ASPRAEIPYBEUEV-UHFFFAOYSA-N (PubChem CID 157217755) has the molecular formula C45H48F10N4O6 and a molecular weight of 930.88 g/mol. Its IUPAC name is 1-[4-[2-(2,4-difluorophenoxy)ethyl]piperazin-1-yl]-4-[4-(trifluoromethoxy)phenyl]butan-1-one;1-[4-[2-(2,4-difluorophenoxy)ethyl]piperazin-1-yl]-3-[4-(trifluoromethoxy)phenyl]propan-1-one.

Molecular Properties

Compound NameASPRAEIPYBEUEV-UHFFFAOYSA-N
PubChem CID157217755
Molecular FormulaC45H48F10N4O6
Molecular Weight930.88 g/mol
Exact Mass930.34
IUPAC Name1-[4-[2-(2,4-difluorophenoxy)ethyl]piperazin-1-yl]-4-[4-(trifluoromethoxy)phenyl]butan-1-one;1-[4-[2-(2,4-difluorophenoxy)ethyl]piperazin-1-yl]-3-[4-(trifluoromethoxy)phenyl]propan-1-one
SMILESO=C(CCCc1ccc(OC(F)(F)F)cc1)N1CCN(CCOc2ccc(F)cc2F)CC1.O=C(CCc1ccc(OC(F)(F)F)cc1)N1CCN(CCOc2ccc(F)cc2F)CC1
InChIInChI=1S/C23H25F5N2O3.C22H23F5N2O3/c24-18-6-9-21(20(25)16-18)32-15-14-29-10-12-30(13-11-29)22(31)3-1-2-17-4-7-19(8-5-17)33-23(26,27)28;23-17-4-7-20(19(24)15-17)31-14-13-28-9-11-29(12-10-28)21(30)8-3-16-1-5-18(6-2-16)32-22(25,26)27/h4-9,16H,1-3,10-15H2;1-2,4-7,15H,3,8-14H2
InChIKeyASPRAEIPYBEUEV-UHFFFAOYSA-N
XLogP8.43
TPSA84.02 Ų
H-Bond Donors
H-Bond Acceptors8
Rotatable Bonds17
Heavy Atoms65
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500930.88
LogP ≤ 58.43
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 108

Analyze ASPRAEIPYBEUEV-UHFFFAOYSA-N with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of ASPRAEIPYBEUEV-UHFFFAOYSA-N?
The IUPAC name of ASPRAEIPYBEUEV-UHFFFAOYSA-N (CID 157217755) is 1-[4-[2-(2,4-difluorophenoxy)ethyl]piperazin-1-yl]-4-[4-(trifluoromethoxy)phenyl]butan-1-one;1-[4-[2-(2,4-difluorophenoxy)ethyl]piperazin-1-yl]-3-[4-(trifluoromethoxy)phenyl]propan-1-one.
What is the SMILES notation for ASPRAEIPYBEUEV-UHFFFAOYSA-N?
The canonical SMILES for ASPRAEIPYBEUEV-UHFFFAOYSA-N is O=C(CCCc1ccc(OC(F)(F)F)cc1)N1CCN(CCOc2ccc(F)cc2F)CC1.O=C(CCc1ccc(OC(F)(F)F)cc1)N1CCN(CCOc2ccc(F)cc2F)CC1.
What is the InChIKey of ASPRAEIPYBEUEV-UHFFFAOYSA-N?
The InChIKey is ASPRAEIPYBEUEV-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H25F5N2O3.C22H23F5N2O3/c24-18-6-9-21(20(25)16-18)32-15-14-29-10-12-30(13-11-29)22(31)3-1-2-17-4-7-19(8-5-17)33-23(26,27)28;23-17-4-7-20(19(24)15-17)31-14-13-28-9-11-29(12-10-28)21(30)8-3-16-1-5-18(6-2-16)32-22(25,26)27/h4-9,16H,1-3,10-15H2;1-2,4-7,15H,3,8-14H2.
What are the key properties of ASPRAEIPYBEUEV-UHFFFAOYSA-N?
ASPRAEIPYBEUEV-UHFFFAOYSA-N has a molecular weight of 930.88 g/mol, XLogP of 8.43, 17 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for ASPRAEIPYBEUEV-UHFFFAOYSA-N is sourced from PubChem (CID 157217755), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.